Refractory Anemia With Ringed Sideroblasts Completed Phase 3 Trials for Aldesleukin (DB00041)

Also known as: Refractory anaemia with ringed sideroblasts / Ringed sideroblasts / Ringed sideroblast / RARS

Indication	Status	Phase
DBCOND0028568 (Refractory Anemia With Ringed Sideroblasts)	Completed	3

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT00002798	Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic Syndrome	Treatment	Aldesleukin (DB00041) Asparaginase Escherichia coli (DB00023) Aspartic acid (DB00128) Busulfan (DB01008) Cyclophosphamide (DB00531) Cytarabine (DB00987) Daunorubicin (DB00694) Dexamethasone (DB01234) Etoposide (DB00773) Filgrastim (DB00099) Fludarabine (DB01073) Hydrocortisone (DB00741) Hydrocortisone cypionate (DB14541) Idarubicin (DB01177) Methotrexate (DB00563) Tioguanine (DB00352)